Comparison of two antifibrotic treatments for lung fibrosis in post-COVID-19 syndrome: A randomized, prospective study

Mostrar otras versiones (1)

BACKGROUND: Although pulmonary fibrosis secondary to COVID-19 infection is uncommon, it can lead to problems if not treated effectively in the early period. This study aimed to compare the effects of treatment with nintedanib and pirfenidone in patients with COVID-19-related fibrosis. METHODS: Thirt...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerget, Buğra, Çil, Gizem, Araz, Ömer, Alper, Fatih, Akgün, Metin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273009/
https://www.ncbi.nlm.nih.gov/pubmed/37337553
http://dx.doi.org/10.1016/j.medcle.2022.12.019

Ejemplares similares

Ejemplares similares